UNSPSC 51385301: Ciproquazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H18N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P8S0GE5Q4I, chemically known as 2(1h)-quinazolinone, 1-(cyclopropylmethyl)-6-methoxy-4-phenyl- but generally known as ciproquazone, which bears US NIH Compound Identifier 36489. European Medicines Agency schedules Ciproquazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07473MIG.

UNSPSC 51385301 Ciproquazone is a Commodity code that, based on recent state and local procurement activity, appears to capture pharmaceutical and medical chemical products procured by health agencies and counties. The scope of work under this code includes the purchase and delivery of specialized pharmaceutical products and medical deactivation systems for community health support. Seminole County, Florida recently solicited naloxone and drug deactivation systems through a competitive bidding process, indicating that state and local issuing bodies use this code to procure life-safety pharmaceuticals and related medical equipment. The work involves product sourcing, logistics coordination, and compliance with federal and state regulations around pharmaceutical distribution, including E-Verify and drug-free workplace certification. County health departments and community health agencies represent the primary issuing bodies under this code.

Seminole County, Florida has posted recent activity under the code. In June 2026, Seminole County released IFB 60459723LAS seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023, and vendors were required to include all shipping and delivery costs in their proposals. The contract carried an initial two-year term with an optional one-year renewal, and awardees were subject to workers' compensation, commercial general liability, and professional liability insurance requirements. The procurement included a three-month probationary period and cited potential FEMA funding, introducing compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. Limited recent-opportunity visibility and the mismatch between the code name (ciproquazone, typically a biocide or agricultural chemical) and the actual procurement (pharmaceutical and medical-device systems) suggest this code may not capture the full scope of state and local buying activity in this space, or that the opportunity was misclassified.